SCHEMBL7052995

SCHEMBL7052995

CCN(CC)CCOc1cccc(Nc2nccc(O)n2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGER Q15109 1/20 0.60
SRC P12931 4/20 0.53
YES1 P07947 2/20 0.53
FGFR1 P11362 1/20 0.51
FGFR2 P21802 1/20 0.51
FGFR4 P22455 1/20 0.51
FGFR3 P22607 1/20 0.51
EGFR P00533 2/20 0.47
KDM4E B2RXH2 1/20 0.46
TSHR P16473 1/20 0.46
MAP3K5 Q99683 1/20 0.44
SYK P43405 4/20 0.44
PIK3CA P42336 2/20 0.44
PIK3CG P48736 2/20 0.44
ABL1 P00519 2/20 0.44
BCR P11274 2/20 0.44
PRKCA P17252 1/20 0.44
PRKCD Q05655 1/20 0.44
PIK3CB P42338 1/20 0.44
ESR1 P03372 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7052367 0.86 AGER (0.66) AGERSRCYES1FGFR1FGFR2
SCHEMBL7466120 0.83 AGER (0.67) AGERSRCYES1FGFR1FGFR2
SCHEMBL13924608 0.82 SYK (0.66) AGERSRCYES1FGFR1FGFR2
SCHEMBL13911400 0.82 EGFR (0.49) SRCEGFRMAP3K5SYKPIK3CA
SCHEMBL7464616 0.81 ABL1 (0.68) AGERSRCEGFRPIK3CAPIK3CG
SCHEMBL7464949 0.81 AGER (0.59) AGERSRCYES1FGFR1FGFR2
SCHEMBL7056569 0.80 ABL1 (0.47) EGFRABL1BCR
SCHEMBL7660259 0.79 AGER (0.55) AGERSRCYES1FGFR1FGFR2
SCHEMBL1736474 0.78 AGER (0.60) AGERSRCYES1FGFR1FGFR2
SCHEMBL7345611 0.78 AGER (0.59) AGERSRCYES1FGFR1FGFR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003026666-A1 2-PHENYLAMINO-4- (5-PYRAZOLYLAMINO)-PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS, IN PARTICULAR, AS SRC KINASE INHIBITORS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed